Tempus AI’s (TEM) “Buy” Rating Reiterated at BTIG Research

BTIG Research reaffirmed their buy rating on shares of Tempus AI (NASDAQ:TEM) in a research note published on Wednesday morning,Benzinga reports. The firm currently has a $96.00 price objective on the stock.

Several other brokerages have also issued reports on TEM. Canaccord Genuity Group decreased their target price on Tempus AI from $110.00 to $95.00 and set a “buy” rating for the company in a research report on Wednesday. HC Wainwright increased their price objective on Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a report on Friday, September 12th. TD Cowen lowered Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price objective for the company. in a research report on Tuesday, October 21st. Piper Sandler upped their target price on shares of Tempus AI from $70.00 to $105.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 22nd. Finally, Needham & Company LLC increased their price target on shares of Tempus AI from $70.00 to $100.00 and gave the stock a “buy” rating in a research note on Wednesday. Seven investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $79.85.

Tempus AI Trading Down 0.7%

Shares of TEM opened at $71.56 on Wednesday. Tempus AI has a 1-year low of $31.36 and a 1-year high of $104.32. The company has a current ratio of 3.28, a quick ratio of 1.43 and a debt-to-equity ratio of 2.45. The firm’s 50-day moving average price is $85.91 and its 200-day moving average price is $70.82. The firm has a market capitalization of $12.43 billion, a price-to-earnings ratio of -60.13 and a beta of 4.86.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. The company had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. Tempus AI’s revenue was up 84.7% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.46) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Sell-side analysts anticipate that Tempus AI will post -6.15 EPS for the current year.

Insider Transactions at Tempus AI

In related news, COO Ryan Fukushima sold 5,000 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $89.03, for a total value of $445,150.00. Following the transaction, the chief operating officer owned 125,000 shares in the company, valued at $11,128,750. The trade was a 3.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Ryan M. Bartolucci sold 1,904 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $142,133.60. Following the sale, the chief accounting officer directly owned 45,895 shares in the company, valued at $3,426,061.75. This trade represents a 3.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 1,105,282 shares of company stock valued at $87,726,381. 26.27% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Tempus AI

Large investors have recently bought and sold shares of the business. GSA Capital Partners LLP purchased a new position in Tempus AI in the 3rd quarter worth about $604,000. Vanguard Group Inc. grew its stake in shares of Tempus AI by 22.1% in the third quarter. Vanguard Group Inc. now owns 9,441,607 shares of the company’s stock worth $762,032,000 after acquiring an additional 1,706,837 shares during the period. State of New Jersey Common Pension Fund D raised its holdings in shares of Tempus AI by 4.2% during the third quarter. State of New Jersey Common Pension Fund D now owns 33,111 shares of the company’s stock valued at $2,672,000 after purchasing an additional 1,323 shares during the last quarter. PNC Financial Services Group Inc. lifted its position in Tempus AI by 16.2% during the third quarter. PNC Financial Services Group Inc. now owns 5,815 shares of the company’s stock valued at $469,000 after purchasing an additional 812 shares during the period. Finally, Ameritas Advisory Services LLC purchased a new stake in Tempus AI in the third quarter worth approximately $843,000. 24.22% of the stock is currently owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.